150 related articles for article (PubMed ID: 31849528)
1. LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint.
Hong L; Wang H; Wang J; Wei S; Zhang F; Han J; Liu Y; Ma M; Liu C; Xu Y; Jiang D
Cancer Manag Res; 2019; 11():10393-10399. PubMed ID: 31849528
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
[TBL] [Abstract][Full Text] [Related]
3. LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT.
Ji L; Chen S; Gu L; Wang J; Zhang X
Cancer Manag Res; 2021; 13():2153-2161. PubMed ID: 33688258
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
5. lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR.
Huang Q; Zhang D; Diao Q; Lin M
Oncol Lett; 2019 Sep; 18(3):2917-2922. PubMed ID: 31452772
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer.
Cai Y; Li Y; Sun B; Wang H; Zhang W; Zhao Y; Zhao H; Zhang J; Xu J; Wang Y
Cancer Manag Res; 2020; 12():8535-8543. PubMed ID: 32982446
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
[No Abstract] [Full Text] [Related]
9. LncRNA PTCSC3 Alleviates the Postoperative Distant Recurrence of Gastric Cancer by Suppression of lncRNA HOXA11-AS.
Xu J; Zhang Y; You Q; Fu H; Zhao X; Lu K; Yan R; Yang D
Cancer Manag Res; 2020; 12():2623-2629. PubMed ID: 32368140
[TBL] [Abstract][Full Text] [Related]
10. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
11. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.
Wang J; Zhao Q
Int Immunopharmacol; 2020 Jul; 84():106497. PubMed ID: 32289665
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PTCSC3 Is a Biomarker for the Treatment and Prognosis of Gastric Cancer.
Zhang G; Chi N; Lu Q; Zhu D; Zhuang Y
Cancer Biother Radiopharm; 2020 Feb; 35(1):77-81. PubMed ID: 31702383
[No Abstract] [Full Text] [Related]
14. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
Wang N; Hou M; Zhan Y; Sheng X
J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG.
Zhang G; Gao L; Zhang J; Wang R; Wei X
Oncol Lett; 2023 Aug; 26(2):331. PubMed ID: 37415630
[TBL] [Abstract][Full Text] [Related]
16. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
[TBL] [Abstract][Full Text] [Related]
17. LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation
Zhang C; Kang T; Wang X; Wang J; Liu L; Zhang J; Liu X; Li R; Wang J; Zhang J
Front Pharmacol; 2022; 13():968223. PubMed ID: 36091809
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
[No Abstract] [Full Text] [Related]
19. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.
Han X; Liu J; Liu Y; Mou L; Li C
Cancer Manag Res; 2021; 13():4393-4401. PubMed ID: 34103994
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PTCSC3 inhibits the proliferation, invasion and migration of cervical cancer cells via sponging miR-574-5p.
Tong R; Zhang J; Wang C; Li X; Yu T; Wang L
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):439-448. PubMed ID: 31587336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
